“…(Glinko, ). Severe adverse events were also not observed in patients treated with willow bark extract, neither in 5 clinical studies over up to 6 weeks (Vlachojannis et al ., ), nor in 3 surveys over 8 weeks including a total of 5871 patients (Werner and Scheithe, , Zenner‐Weber, , Müller‐Faßbender et al ., ) nor in a recently published survey over 6 months including 436 patients (Uehleke et al ., ). The overall adverse event rate during treatment with willow bark extract for chronic back pain, fibromyalgia and/or osteoarthritis was below 3%.…”